Search Results

There are 13237 results for: content related to: Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea

  1. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  2. You have free access to this content
    Chronic hepatitis B

    Hepatology

    Volume 45, Issue 2, February 2007, Pages: 507–539, Anna S. F. Lok and Brian J. McMahon

    Version of Record online : 26 JAN 2007, DOI: 10.1002/hep.21513

  3. You have free access to this content
    AASLD Abstracts 895–1142

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 707A–816A,

    Version of Record online : 24 SEP 2008, DOI: 10.1002/hep.22644

  4. Efficacy of lamivudine re-treatment for relapsed patients after an initial lamivudine therapy in HBeAg-positive chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 12, Issue 4, July 2005, Pages: 393–397, J. W. Shin, N. H. Park, J. H. Park, J. H. Park, I. D. Jeong, S-J. Bang, K. R. Joo and D. H. Kim

    Version of Record online : 14 MAR 2005, DOI: 10.1111/j.1365-2893.2005.00606.x

  5. Abstract Index

    Journal of Gastroenterology and Hepatology

    Volume 19, Issue s7, December 2004, Pages: A676–A868,

    Version of Record online : 3 DEC 2004, DOI: 10.1111/j.1440-1746.2004.03735.x

  6. Management of viral hepatitis B

    Journal of Gastroenterology and Hepatology

    Volume 17, Issue s1, February 2002, Pages: S125–S145, CHUTIMA PRAMOOLSINSUP

    Version of Record online : 8 MAY 2002, DOI: 10.1046/j.1440-1746.17.s1.3.x

  7. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  8. You have free access to this content
    Abstracts 890 to 1096

    Hepatology

    Volume 46, Issue S1, October 2007, Pages: 632A–724A,

    Version of Record online : 19 SEP 2007, DOI: 10.1002/hep.22020

  9. You have free access to this content
    Early virological response predicts outcome during extended lamivudine retreatment in patients with chronic hepatitis B who relapsed after initial HBeAg responses

    Journal of Gastroenterology and Hepatology

    Volume 21, Issue 2, February 2006, Pages: 384–391, JEONG WON JANG, SI HYUN BAE, JONG YOUNG CHOI, CHANG WOOK KIM, NAM IK HAN, JUN YEOL HAN, SANG WOOK CHOI, SEUNG KEW YOON, KYU WON CHUNG and HEE SIK SUN

    Version of Record online : 6 JAN 2006, DOI: 10.1111/j.1440-1746.2005.04035.x

  10. You have free access to this content
    Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B

    Hepatology

    Volume 51, Issue 2, February 2010, Pages: 415–421, Hyun Woong Lee, Heon Ju Lee, Jae Seok Hwang, Joo Hyun Sohn, Jae Young Jang, Ki Jun Han, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Yong Han Paik, Chun Kyon Lee, Kwan Sik Lee, Chae Yoon Chon and Kwang-Hyub Han

    Version of Record online : 9 NOV 2009, DOI: 10.1002/hep.23323

  11. APASL Abstracts, Bali 2005

    Liver International

    Volume 25, Issue 6, December 2005, Pages: 1270–1384,

    Version of Record online : 11 NOV 2005, DOI: 10.1111/j.1478-3231.2005.01182.x

  12. Management of chronic hepatitis B virus infection: a new era of disease control

    Internal Medicine Journal

    Volume 36, Issue 2, February 2006, Pages: 100–113, G. C. Farrell and N. C. Teoh

    Version of Record online : 10 FEB 2006, DOI: 10.1111/j.1445-5994.2006.01027.x

  13. Stopping lamivudine therapy after biochemical breakthrough may be a feasible option in selected HBeAg-positive patients

    Journal of Medical Virology

    Volume 77, Issue 3, November 2005, Pages: 367–373, Jeong Won Jang, Jong Young Choi, Si Hyun Bae, Seung Kew Yoon, Chang Wook Kim, Soon Woo Nam, Chang Don Lee, Young Sok Lee, Sang Bok Cha and Kyu Won Chung

    Version of Record online : 19 SEP 2005, DOI: 10.1002/jmv.20465

  14. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update

    Liver International

    Volume 25, Issue 3, June 2005, Pages: 472–489, Yun-Fan Liaw, Nancy Leung, Richard Guan, George K.K. Lau, Ismail Merican, Geoff McCaughan, Edward Gane, Jia-Horng Kao, Masao Omata and for the Asian-Pacific consensus update working party on chronic hepatitis B

    Version of Record online : 21 MAY 2005, DOI: 10.1111/j.1478-3231.2005.01134.x

  15. Combination therapy of interferon and nucleotide/nucleoside analogues for chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 21, Issue 12, December 2014, Pages: 825–834, G. L.-H. Wong, V. W.-S. Wong and H. L.-Y. Chan

    Version of Record online : 17 NOV 2014, DOI: 10.1111/jvh.12341

  16. Monitoring of HBeAg levels may help to predict the outcomes of lamivudine therapy for HBeAg positive chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 12, Issue 2, March 2005, Pages: 216–221, N. H. Park, J. W. Shin, J. H. Park, S-J. Bang, D-H. Kim, K. R. Joo and D. H. Kim

    Version of Record online : 17 FEB 2005, DOI: 10.1111/j.1365-2893.2005.00602.x

  17. You have free access to this content
    Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B

    Hepatology

    Volume 30, Issue 3, September 1999, Pages: 770–774, Rong-Nan Chien, Yun-Fan Liaw and Mark Atkins

    Version of Record online : 30 DEC 2003, DOI: 10.1002/hep.510300313

  18. You have free access to this content
    Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapy

    Hepatology

    Volume 33, Issue 6, June 2001, Pages: 1527–1532, Nancy W. Y. Leung, Ching-Lung Lai, Ting-Tsung Chang, Richard Guan, Chuan-Mo Lee, Keng-Yeen Ng, Seng-Gee Lim, Pui-Chee Wu, Julie C. Dent, Sally Edmundson, Lynn D. Condreay and Rong-Nan Chien

    Version of Record online : 30 DEC 2003, DOI: 10.1053/jhep.2001.25084

  19. Should lamivudine monotherapy be stopped or continued in patients infected with hepatitis B with favorable responses after more than 5 years of treatment?

    Journal of Medical Virology

    Volume 85, Issue 1, January 2013, Pages: 34–42, Jung Hyun Kwon, Jeong Won Jang, Jong Young Choi, Chung-Hwa Park, Sun Hong Yoo, Si Hyun Bae and Seung Kew Yoon

    Version of Record online : 14 NOV 2012, DOI: 10.1002/jmv.23421

  20. Individual prediction model for lamivudine treatment response in hepatitis B virus e antigen-positive chronic hepatitis B patients

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 5, May 2014, Pages: 1049–1055, Hyun Woong Lee, Wonseok Kang, Sang Hoon Ahn, Heon Ju Lee, Jae Seok Hwang, Joo Hyun Sohn, Jae Young Jang, Ki Jun Han, Ja Kyung Kim, Do Young Kim, Yong Han Paik, Chun Kyon Lee, Ik-Seong Choi, Kwan Sik Lee and Kwang-Hyub Han

    Version of Record online : 21 APR 2014, DOI: 10.1111/jgh.12522